Stay updated on Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.

Latest updates to the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov footer now shows software revision v3.8.0 instead of v3.7.2.SummaryDifference0.0%

- Check12 days agoChange DetectedA new ClinicalTrials.gov record-history entry reflects updates to the study status and contacts/locations. An NIH notice about its terminology transition also appears on the page.SummaryDifference0.1%

- Check19 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check26 days agoChange DetectedThe website footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check47 days agoChange DetectedA new history entry was added for 2026-09-15 including a Study Status update and Revision: v3.7.0, while the previous Revision: v3.6.6 was removed. This reflects maintenance/version tracking rather than substantive changes to the study information.SummaryDifference0.0%

- Check61 days agoChange DetectedA new history entry dated 2026-08-28 adds updated Study Status and Contacts/Locations (Revision: v3.6.6, ID 1019), following the removal of the previous 2026-08-04 revision (v3.6.5).SummaryDifference0.0%

Stay in the know with updates to Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib Trametinib in BRAF Mutant Melanoma Clinical Trial page.